Legler J - Search Results

1

The effectiveness of interventions to promote mammography among women with historically lower rates of screening.

Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. Legler J, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):59-71. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815402

2

Predicting patterns of mammography use: a geographic perspective on national needs for intervention research.

Legler J, Breen N, Meissner H, Malec D, Coyne C. Legler J, et al. Health Serv Res. 2002 Aug;37(4):929-47. doi: 10.1034/j.1600-0560.2002.59.x. Health Serv Res. 2002. PMID: 12236391 Free PMC article.

3

Breast and cervical cancer screening interventions: an assessment of the literature.

Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK. Meissner HI, et al. Among authors: legler jm. Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):951-61. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9796642 Review.

4

Development of a comorbidity index using physician claims data.

Klabunde CN, Potosky AL, Legler JM, Warren JL. Klabunde CN, et al. Among authors: legler jm. J Clin Epidemiol. 2000 Dec;53(12):1258-67. doi: 10.1016/s0895-4356(00)00256-0. J Clin Epidemiol. 2000. PMID: 11146273

5

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. Klabunde CN, et al. Ann Epidemiol. 2007 Aug;17(8):584-90. doi: 10.1016/j.annepidem.2007.03.011. Epub 2007 May 25. Ann Epidemiol. 2007. PMID: 17531502

6

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Hankey BF, et al. Among authors: legler jm. J Natl Cancer Inst. 1999 Jun 16;91(12):1017-24. doi: 10.1093/jnci/91.12.1017. J Natl Cancer Inst. 1999. PMID: 10379964

7

Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.

Cronin KA, Legler JM, Etzioni RD. Cronin KA, et al. Among authors: legler jm. Stat Med. 1998 Nov 15;17(21):2509-23. doi: 10.1002/(sici)1097-0258(19981115)17:21<2509::aid-sim949>3.0.co;2-v. Stat Med. 1998. PMID: 9819842

8

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.

Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. Legler JM, et al. Cancer Causes Control. 1998 Oct;9(5):519-27. doi: 10.1023/a:1008805718310. Cancer Causes Control. 1998. PMID: 9934717

9

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. Legler JM, et al. J Natl Cancer Inst. 1999 Aug 18;91(16):1382-90. doi: 10.1093/jnci/91.16.1382. J Natl Cancer Inst. 1999. PMID: 10451443

10

Assessing comorbidity using claims data: an overview.

Klabunde CN, Warren JL, Legler JM. Klabunde CN, et al. Med Care. 2002 Aug;40(8 Suppl):IV-26-35. doi: 10.1097/00005650-200208001-00004. Med Care. 2002. PMID: 12187165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters